Resumo
Definição
História e exame físico
Principais fatores diagnósticos
- reduced urine production
- vomiting
- dizziness
- orthopnea
- paroxysmal nocturnal dyspnea
- pulmonary edema
- hypotension
- tachycardia
- orthostatic hypotension
- hypertension
- peripheral edema
- muscle tenderness
- limb ischemia
- seizures
- prostatic obstructive symptoms
- hematuria
- fever
- rash
- arthralgia/arthritis
- altered mental status
- signs of uremia
Outros fatores diagnósticos
- nausea
- thirst
- flank pain
- abdominal distention
- abdominal bruit
- livedo reticularis
- petechiae
- ecchymoses
Fatores de risco
- advanced age
- underlying renal disease
- malignant hypertension
- diabetes mellitus
- myeloproliferative disorders, such as multiple myeloma
- connective tissue disease
- sodium-retaining states (e.g., congestive heart failure, cirrhosis, nephrotic syndrome)
- radiocontrast
- exposure to nephrotoxins (e.g., aminoglycosides, vancomycin + piperacillin-tazobactam, cancer therapies, nonsteroidal anti-inflammatory drugs, or ACE inhibitors)
- trauma
- hemorrhage
- sepsis
- pancreatitis
- drug overdose
- surgery
- cardiac arrest
- recent vascular intervention
- excessive fluid loss
- nephrolithiasis
- drug abuse
- alcohol abuse
- excessive exercise
- recent blood transfusion
- malignancy
- genetic susceptibility
- use of renin-angiotensin system inhibitors
- proton pump inhibitors
- herbal therapy
Investigações diagnósticas
Primeiras investigações a serem solicitadas
- basic metabolic profile (including blood urea nitrogen [BUN] and creatinine)
- ratio of serum BUN to creatinine
- urinalysis
- urine culture
- complete blood count
- fractional excretion of sodium
- fractional excretion of urea
- urinary eosinophil count
- venous blood gases
- fluid challenge
- bladder catheterization
- urine osmolality
- urine sodium concentration
- renal ultrasound
- chest x-ray
- ECG
Investigações a serem consideradas
- antinuclear antibodies
- anti-DNA
- complement (C3, C4, CH50)
- anti-glomerular basement membrane antibodies
- antineutrophil cytoplasmic antibodies
- acute hepatitis profile
- HIV serology
- cryoglobulins
- erythrocyte sedimentation rate
- antistreptolysin-O antibody
- abdominal computed tomography or magnetic resonance imaging scan
- nuclear renal flow scan
- cystoscopy
- renal biopsy
Algoritmo de tratamento
Colaboradores
Consultores especialistas
Richard A. Lafayette, MD
Professor of Medicine
Nephrology Division
Stanford University Medical Center
Stanford
CA
Declarações
RAL works as a consultant and researcher for Relypsa, Inc. Although unrelated to this topic area, RAL also works as a consultant for Fibrogen, Inc., Mallinckrodt, Inc., and Omeros, Inc., and as a researcher for Genentech, Inc., Mallinckrodt, Inc., GlaxoSmithKline, Inc., Rigel, Inc., Aurinia, Inc., and the NIH.
Agradecimentos
Dr Richard A. Lafayette would like to gratefully acknowledge Dr Sandra Sabatini, Dr Neil Kurtzman, and Dr Corey D. Ball, the previous contributors to this topic.
Declarações
SS, NK, and CDB declare that they have no competing interests.
Revisores
Garabed Eknoyan, MD
Professor of Medicine
Section of Nephrology
Department of Medicine
Baylor College of Medicine
Houston
TX
Declarações
GE declares that he has no competing interests.
Dominic de Takats, MA, MRCP
Consultant Nephrologist
Nephrology
North Staffs Royal Infirmary
University Hospital of North Staffordshire
Stoke-on-Trent
UK
Declarações
DdT declares that he has no competing interests.
Créditos aos pareceristas
Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.
Declarações
As afiliações e declarações dos pareceristas referem--se ao momento da revisão.
Referências
Principais artigos
Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012 Mar;2(1):1-138.Texto completo
Palevsky PM, Liu KD, Brophy PD, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. Am J Kidney Dis. 2013 May;61(5):649-72.Texto completo Resumo
Moore PK, Hsu RK, Liu KD. Management of acute kidney injury: core curriculum 2018. Am J Kidney Dis. 2018 Jul;72(1):136-48.Texto completo Resumo
Artigos de referência
Uma lista completa das fontes referenciadas neste tópico está disponível aqui.
O uso deste conteúdo está sujeito ao nosso aviso legal